Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The objective of Left atrial appendage closure compared to standard antiplatelet therapy in
patients with AF who underwent percutaneous coronary intervention (LLA-PCI) study is to
evaluate the safety and efficacy of implantation of left atrial appendage closure compared to
standard antiplatelet therapy for prevention of thromboembolic events and stent thrombosis in
subjects with AF who underwent PCI.
Phase:
Phase 2
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation